Focally irradiated area | Â | Â | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Pattern 1 | Pattern 2 | Pattern 3 | |||||||||
KEGG ID | Name | p-value* | FDRa | ID | Name | p-value | FDR | ID | Name | p-value | FDR |
mmu05414 | Dilated cardiomyopathy | 3.31E-09 | 6.08E-07 | mmu04060 | Cytokine-cytokine receptor interaction | 5.25E-17 | 6.78E-15 | mmu04115 | p53 signaling pathway | 4.94E-09 | 1.78E-07 |
mmu05410 | Hypertrophic cardiomyopathy | 1.75E-07 | 1.61E-05 | mmu05322 | Systemic lupus erythematosus | 2.32E-10 | 1.50E-08 | Â | Â | Â | Â |
mmu05412 | Arrhythmogenic right ventricular cardiomyopathy | 5.71E-06 | 3.50E-04 | mmu05332 | Graft-versus-host disease | 1.34E-09 | 5.78E-08 | Â | Â | Â | Â |
mmu04020 | Calcium signaling pathway | 1.24E-05 | 5.71E-04 | mmu05330 | Allograft rejection | 1.81E-09 | 5.83E-08 | Â | Â | Â | Â |
mmu00982 | Drug metabolism | 1.85E-05 | 6.81E-04 | mmu04142 | Lysosome | 2.10E-09 | 5.42E-08 | Â | Â | Â | Â |
mmu04530 | Tight junction | 1.15E-04 | 3.53E-03 | mmu04612 | Antigen processing and presentation | 4.62E-09 | 9.93E-08 | Â | Â | Â | Â |
mmu04360 | Axon guidance | 1.58E-04 | 4.14E-03 | mmu04940 | Type I diabetes mellitus | 7.14E-09 | 1.32E-07 | Â | Â | Â | Â |
 |  |  |  | mmu05310 | Asthma | 2.00E-08 | 3.23E-07 |  |  |  |  |
 |  |  |  | mmu04062 | Chemokine signaling pathway | 7.04E-08 | 1.01E-06 |  |  |  |  |
 |  |  |  | mmu04514 | Cell adhesion molecules (CAMs) | 1.51E-07 | 1.94E-06 |  |  |  |  |
 |  |  |  | mmu04650 | Natural killer cell mediated cytotoxicity | 2.78E-07 | 3.26E-06 |  |  |  |  |
 |  |  |  | mmu04672 | Intestinal immune network for IgA production | 9.21E-07 | 9.90E-06 |  |  |  |  |
 |  |  |  | mmu05340 | Primary immunodeficiency | 1.10E-05 | 1.09E-04 |  |  |  |  |
 |  |  |  | mmu05320 | Autoimmune thyroid disease | 1.11E-05 | 1.03E-04 |  |  |  |  |
 |  |  |  | mmu05416 | Viral myocarditis | 1.25E-05 | 1.08E-04 |  |  |  |  |
 |  |  |  | mmu04660 | T cell receptor signaling pathway | 1.95E-05 | 1.57E-04 |  |  |  |  |
 |  |  |  | mmu04640 | Hematopoietic cell lineage | 1.55E-04 | 1.17E-03 |  |  |  |  |
 |  |  |  | mmu04666 | Fc gamma R-mediated phagocytosis | 5.51E-04 | 3.94E-03 |  |  |  |  |
 |  |  |  | mmu04610 | Complement and coagulation cascades | 8.61E-04 | 5.82E-03 |  |  |  |  |
 |  |  |  | mmu04621 | NOD-like receptor signaling pathway | 9.22E-04 | 5.93E-03 |  |  |  |  |
 |  |  |  | mmu04670 | Leukocyte transendothelial migration | 1.19E-03 | 7.32E-03 |  |  |  |  |
 |  |  |  | mmu04662 | B cell receptor signaling pathway | 1.43E-03 | 8.41E-03 |  |  |  |  |
Neighboring area | Â | Â | |||||||||
Pattern 1 | Pattern 2 | Pattern 3 | |||||||||
KEGG ID | Name | p-value | FDR | ID | Name | p-value | FDR | ID | Name | p-value | FDR |
mmu00982 | Drug metabolism | 8.90E-06 | 1.67E-03 | mmu04060 | Cytokine-cytokine receptor interaction | 3.39E-08 | 2.89E-06 | NA | NA | NA | NA |
mmu05410 | Hypertrophic cardiomyopathy | 8.99E-05 | 8.41E-03 | mmu04062 | Chemokine signaling pathway | 1.36E-05 | 5.80E-04 | Â | Â | Â | Â |
mmu04260 | Cardiac muscle contraction | 1.36E-04 | 8.46E-03 | mmu04620 | Toll-like receptor signaling pathway | 2.68E-05 | 7.58E-04 | Â | Â | Â | Â |
mmu04010 | MAPK signaling pathway | 1.80E-04 | 8.44E-03 | Â | Â | Â | Â | Â | Â | Â | Â |
mmu05414 | Dilated cardiomyopathy | 1.93E-04 | 7.24E-03 | Â | Â | Â | Â | Â | Â | Â | Â |